Tebentafusp
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 167 publications
Current Therapies and Potential Strategies for Uveal Melanoma.
Journal: Drugs and drug candidates
Published: February 25, 2026
Adverse Events and Toxicity of Systemic Treatments for Uveal Melanoma: A Systematic Review.
Journal: Cancers
Published: January 28, 2026
Rectus Muscle Metastasis from Primary Uveal Melanoma: A Case Series and Literature Review.
Journal: Ocular oncology and pathology
Published: December 18, 2025
Commentary: Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis.
Journal: Frontiers in oncology
Published: December 14, 2025
Recent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma.
Journal: Melanoma research
Published: December 14, 2025
Total tumor volume and growth rate at 3 months on MRI outperform baseline imaging and circulating tumor DNA for predicting survival of patients with metastatic uveal melanoma receiving tebentafusp.
Journal: Diagnostic and interventional imaging
Published: December 09, 2025
Current Treatment Standards for Metastatic Uveal Melanoma.
Journal: Cancers
Published: December 03, 2025
Circulating tumor DNA accelerates diagnosis and treatment guidance for metastatic uveal melanoma with hepatic lesions not amenable to biopsy.
Journal: Melanoma research
Published: November 08, 2025
Bispecific T-Cell Engagers, Cell Therapies, and Other Non-Checkpoint Immunotherapies for Metastatic Uveal Melanoma: A Narrative Review.
Journal: Journal of clinical medicine
Published: October 12, 2025
Last Updated: 04/28/2026